MoneyWorks4Me

Divis Laboratories informs about annual secretarial compliance report

01 Jun 2021 Evaluate

Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular no CIR/CFD/CMD1/27/2019 dated February 08, 2019, Divis Laboratories has submitted the Annual Secretarial Compliance Report for the year ended 31 March, 2021 issued by V. Bhaskara Rao, Practicing Company Secretary, Hyderabad.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1759.10
Dr. Reddys Labs. 1230.50
Cipla 1313.70
Lupin 1946.00
Zydus Lifesciences 1139.00
View more..